Compare U.S. Stocks

Put up to three companies side by side on valuation, growth, profitability, and debt.

Metric	PFEPfizer	BMYBristol Myers Squibb	GSKGSK plc
Snapshot
Price	$26.46	$64.49	$52.81
Market cap	$138.61B	$118.71B	$102.51B
Valuation
P/E	20.1x	22.1x	13.8x
Forward P/E	21.2x	17.5x	9.8x
Growth
Revenue growth	1.4%	1.8%	4.0%
EPS growth	-5.3%	26.3%	86.7%
Profitability
Net margin	11.8%	12.3%	17.8%
ROE	8.4%	41.6%	35.8%
Balance sheet & cash
Debt / equity	0.75x	2.44x	1.08x
Free cash flow yield	11.2%	15.4%	3.8%
Dividend yield	6.6%	4.5%	3.5%
Verdict
Investment rating	Neutral· 48	Favorable· 60	Favorable· 66

5-Year Price Projections

Base case

Projected using each stock's current EPS, growth rate (EPS or revenue growth), and P/E ratio. P/E assumed to compress 25% on the low end and remain steady on the high end. Not a forecast — for comparative analysis only.

Year	PFEtoday $26	BMYtoday $64	GSKtoday $53
2027	$20.24 – $29.69+12% CAGR	$61.07 – $89.57+39% CAGR	$73.96 – $108.47+105% CAGR
2028	$20.65 – $30.28+7% CAGR	$77.12 – $113.11+32% CAGR	$138.10 – $202.55+96% CAGR
2029	$21.06 – $30.89+5% CAGR	$97.38 – $142.82+30% CAGR	$257.88 – $378.23+93% CAGR
2030	$21.48 – $31.51+4% CAGR	$122.96 – $180.34+29% CAGR	$481.54 – $706.26+91% CAGR
2031	$21.91 – $32.14+4% CAGR	$155.26 – $227.71+29% CAGR	$899.18 – $1,318.80+90% CAGR
5-yr CAGR	-3.7% – 4.0%	19.2% – 28.7%	76.3% – 90.3%